Association between serum transaminase levels and insulin resistance in euthyroid and non-diabetic adults: Serum transaminase levels and insulin resistance in healthy adults
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Yamamoto, Jin MarcosPadro-Nuñez, Sebastian
Guarnizo-Poma, Mirella
Lazaro-Alcantara, Herbert
Paico-Palacios, Socorro
Pantoja-Torres, Betzi
del Carmen Ranilla-Seguin, Vitalia
Benites-Zapata, Vicente A.
Issue Date
2020-01-01
Metadata
Show full item recordPublisher
Elsevier LtdJournal
Diabetes and Metabolic Syndrome: Clinical Research and ReviewsDOI
10.1016/j.dsx.2019.11.013Additional Links
https://linkinghub.elsevier.com/retrieve/pii/S1871-4021(19)30574-0Abstract
Aim: To evaluate the association between elevated serum transaminase levels and insulin resistance (IR) in a population of healthy individuals. Methods: We define IR with a cut-off point of homeostatic model assessment (HOMA-IR) ≥ 3.8. For aspartate aminotransferase (AST), we consider elevated values >30 U/L in women and values >36 U/L in men. For alanine aminotransferase (ALT), we consider elevated values >30 U/L in women and values >40 U/L in men. We performed a crude and adjusted generalized linear model from Poisson family with robust variance, in order to evaluate the association between elevated serum transaminase levels and IR. The associations were presented as prevalence ratio (PR) with their respective 95% confidence intervals (95% CI). Results: We included 261 participants in the study. The median age was 39 years (31–45) and 23.7% of the participants were men. The prevalence of elevated serum transaminase for AST and ALT were, 13.8% and 26.1%, respectively. The prevalence of IR was 34.1%. In the crude analysis we found statistical significance between elevated AST and ALT with IR (PR = 3.18; 95% CI: 2.33–4.34 and PR = 2.44; 95% CI: 1.88–3.30; respectively). However, in the multivariate analysis, the association only remained statistically significance with ALT, but lost its significance with AST, PR = 1.90; CI 95%: 1.31–2.77 and a PR = 1.23; CI 95%: 0.93–1.61; respectively. Conclusion: Elevated serum levels of ALT were associated with insulin resistance. ALT could be used in clinical practice as an additional tool to assess IR in apparently healthy people.Type
info:eu-repo/semantics/articleRights
info:eu-repo/semantics/openAccessAttribution-NonCommercial-ShareAlike 4.0 International
Language
engISSN
18714021EISSN
18780334Sponsors
Dirección de Gestión de la Investigación, Universidad de Antofagastaae974a485f413a2113503eed53cd6c53
10.1016/j.dsx.2019.11.013
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons